Mereo BioPharma Group plc (MAH0) — Capital Reinvestment Ratio

Latest as of June 2021: 0.05x

Mereo BioPharma Group plc (MAH0) has a Capital Reinvestment Ratio of 0.05x as of June 2021, meaning it reinvests 0% of its operating cash flow (€4.95 Million) in capital expenditures (€267.50K). Check Mereo BioPharma Group plc (MAH0) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.05x

Capex / Operating Cash Flow

Operating Cash Flow

€4.95 Million

EUR

Capital Expenditures

€267.50K

EUR

Data as of

Jun 2021

Most recent filing

Annual Capital Reinvestment Ratio for Mereo BioPharma Group plc (None–None)

Year-by-year Capital Reinvestment Ratio for Mereo BioPharma Group plc from None to None. See Mereo BioPharma Group plc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow